DA Value Investment

DA Value Investment, established in 2017, is a venture capital firm headquartered in Seoul, South Korea. It focuses on investing in early-stage companies within the technology, financial services, and information technology sectors.

Jin-oh Park

Vice President

24 past transactions

Sapien Semiconductor

Venture Round in 2023
Sapien Semiconductors is a fabless semiconductor manufacturing company focused on the design and development of application-specific integrated circuits (ASICs). The company specializes in display driver integrated circuits (ICs) optimized for Micro- and Mini-LED displays, which are gaining prominence in the next-generation flat display industry. By providing customized solutions, Sapien Semiconductors caters to a global market, positioning itself at the forefront of display technology innovation.

Dareesoft

Series A in 2022
Dareesoft specializes in providing real-time road hazard information services. The company has developed an advanced system that integrates artificial intelligence, big data, and connectivity technologies to monitor and visualize road hazards effectively. With a lightweight and high-performance AI model, Dareesoft's solution enables users to automatically detect road hazards as they occur, enhancing safety and awareness on the roads. The combination of these technologies allows for the delivery of timely and accurate hazard information, benefiting a wide range of customers who prioritize road safety.

Safehouse

Seed Round in 2022
Safehouse is a story production company that develops a variety of story content.

Dankkumi

Series B in 2022
Dankkumi is an educational platform focused on providing engaging historical stories for children. The company aims to make learning enjoyable by offering informative content in the humanities, designed to encourage independent thinking and emotional engagement among young learners. Through a variety of diverse narratives, Dankkumi seeks to enhance children's understanding of history while fostering a love for learning.

Supergate

Series A in 2022
Supergate is a technology company specializing in computing and artificial intelligence solutions. It offers AI-driven safety systems such as PPE Detection, Fall Detection, and Perimeter Protection Detection, along with System-on-Chip (SoC) designs for high-performance computing and autonomous driving. The company also provides end-to-end custom AI solutions, including AI cameras, edge AI boxes, and tailored vision AI solutions, catering to diverse industries.

Huniverse

Series B in 2022
Huniverse Global is a healthcare IT provider specializing in advanced technologies, primarily through its cloud-based Precision Medicine Hospital Information System (P-HIS). This comprehensive solution addresses all processes within hospitals and utilizes structured data, making it a central component of a digital healthcare environment. By integrating big data and artificial intelligence, Huniverse aims to enhance prediction, diagnosis, and treatment methods, ultimately improving patient care and disease prevention. The company adheres to international standards, positioning itself to expand into global markets as it prepares to launch its innovative solutions beyond its initial local clientele.

HOMES

Series B in 2022
HOMES is a South Korean company established in 2015, specializing in shared housing and living services aimed at single-person households. Headquartered in Seoul, the company offers a platform that integrates real estate development and rental management, focusing on essential aspects of a home, including insulation, soundproofing, lighting, storage, and security. By providing shared spaces such as lounges, dining areas, and laundry facilities, HOMES enhances the living experience for its users, promoting comfort and convenience in urban living environments.

AMCG

Series A in 2021
AMCG is a developer of medical diagnostic devices focused on detecting cardiac-related conditions. The company leverages applied computer science, artificial intelligence, and big data to create innovative diagnostic imaging platforms. These technologies enhance the accuracy and efficiency of image diagnosis, thereby enabling healthcare professionals to identify and assess various medical conditions, particularly heart diseases. By integrating advanced methodologies into their diagnostic devices, AMCG aims to improve patient outcomes and support medical practitioners in delivering effective healthcare solutions.

42dot

Series A in 2021
42dot is a technology company focused on revolutionizing transportation services through innovative solutions. It develops advanced technologies and platforms that integrate autonomous driving, connected vehicles, and smart city infrastructure. By facilitating Mobility-as-a-Service, 42dot allows users to access various transportation modes—such as autonomous shuttles, ride-sharing, and delivery services—via a unified digital interface. The company's platform encompasses a comprehensive range of mobility and logistics services, including ride-hailing, robot taxis, and smart logistics, aimed at providing clients with affordable access to autonomous driving technology.

Soomvi

Series B in 2021
Soomvi is a company focused on the industrial drone market, specializing in marine lifesaving systems. The firm develops advanced drones equipped with technology that enables them to recognize and learn from their environment, ensuring enhanced security and operational performance. These drones feature a sensor-isolated and vibration-resistant design, which contributes to their reliability in various applications. Soomvi's drones also offer real-time synchronization and communication capabilities, allowing for effective monitoring of flight information and backup control system operations. This technology positions Soomvi as a key player in providing innovative solutions for industrial needs, particularly in maritime safety.

NetTargets

Series A in 2021
NetTargets specializes in AI-driven drug discovery research services, aiming to identify novel drug targets. The company has developed a platform that integrates systems biology with machine learning techniques to analyze a wide array of data, including chemical, biological, experimental, and clinical information. By leveraging this comprehensive approach, NetTargets enhances the efficiency and effectiveness of drug discovery processes for pharmaceutical companies, facilitating the development of new therapeutic options.

Newracle Genetics

Series B in 2021
Newracle Genetics is a bio venture company that develops gene therapy products for neurological diseases.

Rosetta Exosome

Series A in 2021
Rosetta Exosome is a medical company focused on developing exosome purification kits aimed at enhancing diagnostics and therapeutics for challenging diseases. The company has created a technology that facilitates the isolation of exosomes or extracellular vesicles from mammalian cell-conditioned media and biological fluids. This innovative approach provides researchers with advanced tools for studying mammalian biology, thereby supporting the advancement of medical research and potential treatment options.

Qureator

Series A in 2021
Qureator specializes in developing micro-physiological systems (MPS), specifically their product known as Curiochips, which are engineered to replicate the complexities of tissue microenvironments. These systems create optimal microscale 3D cell culture conditions that are beneficial for various biomedical research applications. By enhancing the accuracy of clinical trials and improving the efficiency of drug development, Qureator's technology offers a viable alternative to traditional animal testing. This approach not only reduces the duration of clinical trials by minimizing the need for multiple administrations but also decreases the potential for errors, ultimately enabling the healthcare industry to test new drugs in a more ethical and effective manner.

IntoCell

Series C in 2021
Intocell Inc. is a biotechnology company based in Daejeon, South Korea, established in 2015. The company specializes in the development and commercialization of a novel antibody-drug conjugate (ADC) platform aimed at addressing unmet medical needs. Intocell's technologies include proprietary linkers, such as the Ortho-Hydroxy Protected Aryl Sulfate (OHPAS) cleavable linker, along with unique payloads and payload modification techniques. By creating protein-drug and antibody-drug complexes, Intocell focuses on advancing biopharmaceuticals to enhance treatment options for patients with various diseases.

Ziptoss

Series B in 2020
Ziptoss Co., Ltd., established in 2016 and based in Seoul, South Korea, operates an online platform that facilitates the search for rental properties in the country. The company's core business is to disrupt the South Korean real estate industry by offering a free brokerage service for tenants, providing transparent information and reliable offline fees. Ziptoss's services include an application that offers online property listings, sales advertisements, and brokerage services for foreign tenants, all while directly sourcing data from landlords, enabling tenants to secure accommodations without incurring third-party fees.

Scandi Edu

Series A in 2020
Scandi Edu operates 'Brain Now', a reading and language education program for right brain stimulation of infants and toddlers.

Copin Communications

Series A in 2020
Copin Communications, Inc. is a South Korean company based in Seoul that specializes in developing content, including characters and emoticons, for corporate clients. The firm designs emoticon characters and character manuals, catering to a diverse range of genres, such as fantasy, romance, and BL (Boys' Love) in the webtoon format. Copin Communications places a strong emphasis on customer service, addressing inquiries through both phone and email.

Copin Communications

Series A in 2019
Copin Communications, Inc. is a South Korean company based in Seoul that specializes in developing content, including characters and emoticons, for corporate clients. The firm designs emoticon characters and character manuals, catering to a diverse range of genres, such as fantasy, romance, and BL (Boys' Love) in the webtoon format. Copin Communications places a strong emphasis on customer service, addressing inquiries through both phone and email.

Apptest.ai

Seed Round in 2019
Apptest.ai is an AI-powered automated mobile quality assurance and testing solution aimed at eliminating mobile app crashes for users. The company has developed an application testing platform that allows for an efficient exploratory testing experience by utilizing a bot AI engine to understand and navigate app screens, identifying critical errors without the need for extensive scripting or workflow design. The platform includes features such as account creation, user login, continuous integration and continuous delivery (CI/CD) pipeline integration, input validation, memory performance logging, and screen loading speed assessment. With offices in the United States and Seoul, Apptest.ai provides developers with the tools necessary to detect errors effectively and reduce associated costs in the app development process.

Cheongdam Global

Venture Round in 2019
Cheongdam Global Co., Ltd. is a South Korean company based in Incheon that specializes in the distribution, marketing, and export of cosmetic products. Founded in 2017, the company offers a range of brands, including WE.de and Lumiebel. Its product line features items such as the Lumiebel edel creamy ampoule, Lumiebel edel barrier cream, and WE.de jolly lip. In addition to product distribution, Cheongdam Global provides comprehensive solutions encompassing consulting, marketing, and sales to facilitate the successful establishment of brands in the market. The company also engages in product excavation, analysis, validation, and data building to support its operations.

Genesis Lab

Series A in 2018
Genesis Lab, Inc. specializes in developing artificial intelligence-driven behavior analysis solutions aimed at enhancing human-machine communication. The company offers a range of products, including Viewinter.ai, a non-verbal behavior analysis tool designed to help job seekers prepare for video interviews, and Genesis Drive, which monitors driver drowsiness and distractions while assessing the emotional state of both drivers and passengers to enhance interactions and services. Additionally, Genesis Lab provides the Genesis Emotion AI SDK/API, enabling various industries to integrate emotion recognition technology into their applications. The company's mobile offerings include OREO, an application that humorously analyzes emotions, age, and gender from photos, and EMO, a gaming app that allows users to express and mimic emotions through facial expressions. Founded in 2017 and headquartered in Seoul, South Korea, Genesis Lab continues to innovate in the realm of AI behavior analysis.

Lemonex

Series B in 2018
Lemonex Inc. is a biotechnology company based in Seoul, South Korea, founded in 2013. It specializes in the development and commercialization of biotherapeutics aimed at treating cancers and other challenging diseases. The company focuses on cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. Lemonex offers innovative drug delivery solutions, including DegradaBALL, which facilitates the delivery of drug candidates into cultured cells and lesions, and PANGO, a technology for the rapid screening of antiviral drugs. Additionally, Lemonex is engaged in advancing biosensor technology, enhancing the effectiveness of drug delivery methods for healthcare professionals.

Generate great Experiance

Generate great Experiance is an IT company that develops IoT equipment for medical platform.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.